Your account is not claimed yet. You can sign up with ORCID to claim your account.

Nicolas Masurier

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

Medicinal research reviews

Archiv der Pharmazie

Université de Montpellier Faculté de Pharmacie

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université de Montpellier Faculté de Pharmacie Sep 1o 2017

France

Professeur de Chimie Thérapeutique

Publications

Hesham Haffez, Nosaiba A Elsayed, Marwa F Ahmed, Samar S Fatahala, Eman F Khaleel, Rehab Mustafa Badi, Eslam B Elkaeed, Mahmoud A El Hassab, Sherif F Hammad, Wagdy M Eldehna, Nicolas Masurier, Radwan El-Haggar
Novel N -Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Marwa F Ahmed, Radwan El-Haggar, Atiah H Almalki, Omeima Abdullah, Mahmoud A El Hassab, Nicolas Masurier, Sherif F Hammad
Novel hydrazone-isatin derivatives as potential EGFR inhibitors: Synthesis and in vitro pharmacological profiling. Archiv der Pharmazie (2023)
Romain Mustière, Prisca Lagardère, Sébastien Hutter, Céline Deraeve, Florian Schwalen, Dyhia Amrane, Nicolas Masurier, Nadine Azas, Vincent Lisowski, Pierre Verhaeghe, Dominique Mazier, Patrice Vanelle, Nicolas Primas
Pd-catalyzed C-C and C-N cross-coupling reactions in 2-aminothieno[3,2- d ]pyrimidin-4(3 H )-one series for antiplasmodial pharmacomodulation. RSC advances 12 (31) (2022)
Ibrahim H Eissa, Radwan El-Haggar, Mohammed A Dahab, Marwa F Ahmed, Hazem A Mahdy, Reem I Alsantali, Alaa Elwan, Nicolas Masurier, Samar S Fatahala
Design, synthesis, molecular modeling and biological evaluation of novel Benzoxazole-Benzamide conjugates via a 2-Thioacetamido linker as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Prisca Lagardère, Romain Mustière, Nadia Amanzougaghene, Sébastien Hutter, Jean-François Franetich, Nadine Azas, Patrice Vanelle, Pierre Verhaeghe, Nicolas Primas, Dominique Mazier, Nicolas Masurier, Vincent Lisowski
4-Substituted Thieno[3,2- d ]pyrimidines as Dual-Stage Antiplasmodial Derivatives. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Cyril Fersing, Nicolas Masurier, Léa Rubira, Emmanuel Deshayes, Vincent Lisowski
AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Yohan Malki, Jean Martínez, Nicolas Masurier
1,3-Diazepine: A privileged scaffold in medicinal chemistry. Medicinal research reviews 41 (4) (2021)
Prisca Lagardère, Cyril Fersing, Nicolas Masurier, Vincent Lisowski
Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents. Pharmaceuticals (Basel, Switzerland) 15 (1) (2021)
Paul Le Baccon-Sollier, Yohan Malki, Morgane Maye, Lamiaa Mohamed Ahmed Ali, Laure Lichon, Pierre Cuq, Laure-Anaïs Vincent, Nicolas Masurier
Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2020)
Nicolas Masurier, Dominique P Arama, Chahrazade El Amri, Vincent Lisowski
Inhibitors of kallikrein-related peptidases: An overview. Medicinal research reviews 38 (2) (2017)

Nicolas Masurier.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nicolas Masurier